On Friday afternoon, Gov. Chris Sununu vetoed HB 364, the bill that would allow registered patients and caregivers to cultivate a limited supply of cannabis at home. This is a very disappointing development, but it's possible that the House and Senate can be persuaded to pass the bill into law despite the governor's veto.
In order to override the veto, two-thirds majorities will be necessary in both the House and Senate. The House has voted by more than two-thirds to support home cultivation bills on several occasions in the past, and the Senate voted 14-10 in support of HB 364 on May 2. This means two additional votes will be needed in order to reach two-thirds in the Senate.
If you have a personal story to share with legislators about how allowing home cultivation would make a positive difference in your life or the life of a patient you know, please include that in your emails to legislators. If you're comfortable having your story shared with legislators or the public, please send details to me at firstname.lastname@example.org.
After you email your representatives and senator, please share this important update with your friends and family!
Students in Illinois who require access to medical cannabis during school hours were granted relief earlier in August, when Gov. Bruce Rauner signed Ashley’s Law into law. This marked a major step forward for patients, including the new law’s namesake, Ashley Surin, who sought access to help manage her seizure condition. Another bill, which would allow those prescribed opioids to qualify for the state program, is still awaiting the governor’s signature.
The governor only has until August 28 to sign, amend, or reject the bill.
The Opioid Alternative Pilot Program Act, which passed on May 31, not only allows those who could be prescribed opioid drugs to qualify for the medical cannabis program, it also dramatically improves current law by streamlining wait times and removing fingerprint requirements for patients. For a summary written by bill supporters — including key changes to background checks and shortened approval process — click here. The final bill draft language is here.
Gov. Rauner needs to hear from those who support this important change. If you are an Illinois resident, please click here to send an email message to his office.
Earlier this year, the Hawaii Legislature overwhelmingly approved SB 2407, which would allow opioid and substance use disorders, and their symptoms, to be treated with medical cannabis if a physician recommends it. But last week, Gov. David Ige announced he intends to veto this compassionate bill.
Medical cannabis can ease the devastating symptoms of opiate withdrawal and make it easier for individuals to stay on treatment regimens. For some, this is an issue of life or death.
The governor has until July 10 to act on the bill. If you are a resident of Hawaii, please call Gov. Ige at 808-586-0034 or send him an email to urge him to reconsider. We’ve provided some talking points and a draft email message to make the process easy.
The Illinois General Assembly passed the Opioid Alternative Pilot Program Act yesterday during a whirlwind last day of its regular legislative session. If signed into law, SB 336 would allow those who could be prescribed opioid drugs to qualify for the medical cannabis program. It also dramatically improves current law by streamlining wait times and removing fingerprint requirements for patients.
This bill would provide welcome relief to thousands who need a safer alternative to harmful opioid drugs. For a summary written by bill supporters — including key changes to background checks and shortened approval process — click here. The final bill draft language is here.
A huge shout-out goes to the medical cannabis community, the warriors who worked so hard to make it happen, and primary bill sponsors, Sen. Don Harmon and Rep. Kelly Cassidy, and co-sponsors for their leadership and support. Thousands of lives could improve as a result.
But without the governor’s signature, it won’t become a reality. Gov. Rauner has 60 days from the day he receives it to sign or veto the measure, and he needs to hear from you. If you are an Illinois resident, please take a moment to voice your support for the measure with the governor’s office.
The Illinois House of Representatives may soon vote on SB 336, which would allow those who could be prescribed opioid drugs to qualify for the Medical Cannabis Pilot Program. Last month, the Senate passed the measure by a wide margin, but its future in the House is less certain.
While opioids can be highly addictive and dangerous, many seriously ill patients across the country are opting for a safer alternative. Medical cannabis has emerged as an effective option for hundreds of thousands of patients around the U.S. Yet, Illinois’ medical cannabis law does not include pain as a qualifying condition. It’s past time to allow patients to use cannabis instead of opiate-based medications.
Another bill which would also provide patients welcome relief passed both chambers and is now on Gov. Bruce Rauner’s desk. If signed, HB 4870 would allow students who are registered patients to access medical cannabis at school under certain circumstances. While limited, it is an important improvement to ensure patients do not have to choose between their health and their education. If you are an Illinois resident, call Gov. Rauner at (217) 782-0244 and ask him to sign this important bill into law.
The Pennsylvania Health Secretary Rachel Levine announced the department will implement all of the advisory board’s recommended changes to the medical marijuana program. They include:
- Allowing patients to use whole plant, flower cannabis via vaporization.
- Rewording the qualifying condition “severe chronic or intractable pain” to delete the phrase “in which conventional therapeutic intervention and opiate therapy is contraindicated or ineffective.”
- Allowing patients to qualify if they are undergoing “addiction substitute therapy — opioid reduction.”
- Adding the following conditions to the program: cancer while in remission therapy, neurodegenerative diseases, dyskinetic and spastic movement disorders, and terminal illness.
- Eventually requiring minor patients to have recommendations from a pediatrician or other pediatric or adolescent health specialist. (This could be problematic due to the very small number of pediatricians who are recommending cannabis.)
The department will promulgate regulations with these changes on May 12, and they will then undergo legislative review.
These changes would have a major impact for Pennsylvania patients. Allowing cannabis in its flower form is crucial to affordability. And with the revised wording for severe pain, Pennsylvania will no longer steer pain patients to more dangerous medications, such as opiates.